A Phase III Double-Blind, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX(TM) Administered Concomitantly Versus Non-Concomitantly With PNEUMOVAX(TM) 23 in Subjects 60 Years of Age and Older
Latest Information Update: 09 May 2022
At a glance
- Drugs Pneumococcal vaccine (Primary) ; Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster; Pneumococcal infections
- Focus Pharmacodynamics; Registrational
- Sponsors Merck & Co; Merck Sharp & Dohme
- 15 Jun 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
- 15 Jun 2019 This trial has been completed in Spain, according to European Clinical Trials Database.
- 05 May 2010 Primary endpoint identified as geometric mean antibody titre as reported by ClinicalTrials.gov.